Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ADMA

Adma Biologics (ADMA)

Adma Biologics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ADMA
DateTimeSourceHeadlineSymbolCompany
05/02/20246:00AMGlobeNewswire Inc.ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024NASDAQ:ADMAAdma Biologics Inc
03/11/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
03/11/202411:19AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ADMAAdma Biologics Inc
03/11/20246:00AMGlobeNewswire Inc.ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®NASDAQ:ADMAAdma Biologics Inc
03/08/20248:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
03/05/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
03/05/20246:00AMGlobeNewswire Inc.ADMA Biologics to Participate in the Raymond James Institutional Investor ConferenceNASDAQ:ADMAAdma Biologics Inc
03/04/20248:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
02/28/20248:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
02/28/20248:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
02/28/20248:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
02/28/20248:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
02/28/20248:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
02/28/20248:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
02/28/20243:21PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
02/28/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
02/28/20243:10PMGlobeNewswire Inc.ADMA Biologics Announces CFO TransitionNASDAQ:ADMAAdma Biologics Inc
02/28/20243:05PMGlobeNewswire Inc.ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
02/27/20248:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
02/21/20243:05PMGlobeNewswire Inc.ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024NASDAQ:ADMAAdma Biologics Inc
02/21/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
02/21/20246:00AMGlobeNewswire Inc.ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlyticsNASDAQ:ADMAAdma Biologics Inc
02/14/202410:50AMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ADMAAdma Biologics Inc
01/08/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
01/08/20246:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
01/08/20246:00AMGlobeNewswire Inc.ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business UpdateNASDAQ:ADMAAdma Biologics Inc
01/05/20248:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADMAAdma Biologics Inc
12/18/20233:05PMGlobeNewswire Inc.ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares ManagementNASDAQ:ADMAAdma Biologics Inc
12/12/20233:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMAAdma Biologics Inc
12/12/20236:00AMGlobeNewswire Inc.ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and OlderNASDAQ:ADMAAdma Biologics Inc
 Showing the most relevant articles for your search:NASDAQ:ADMA